Has Mark Gromski, MD received payments from drug or device companies?

Yes. Drug and device makers reported $154,240 in general payments to Mark Gromski, MD across 189 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Gromski, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Gromski, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Gromski, MD

Gastroenterology · Indianapolis, INNPI 1255625679

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $101,468 of the $154,240 with a category attached, or 65.8%. Boston Scientific accounts for 71.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $41,702, more than ten times the $2,344 reported in 2019. Among gastroenterology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$154,240in general payments, 2019–2025

Across 189 payments — averaging $816.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$109K
Wilson Cook Medical Incorporated$26K
Ambu A/s$12K
Cook Research Incorporated$3K
Cook Medical LLC$2K
Ambu Inc.$767
plus $699 from 6 others

$253,500in research payments, 2019–2025

Across 3 payments — averaging $84,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Olympus Corporation Of The Americas$243K
Laborie Medical Technologies Corp.$11K

What the payments were for

Consulting fees$40,25626%
Speaking & faculty fees$101,46866%
Travel & lodging$7,1125%
Food & beverage$5,4054%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	150	$109,463
Wilson Cook Medical Incorporated	12	$26,084
Ambu A/s	1	$12,403
Cook Research Incorporated	1	$3,000
Cook Medical LLC	12	$1,824
Ambu Inc.	4	$767
Omega Medical Imaging, LLC	2	$173
Olympus America Inc.	1	$149
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$131
Conmed Corporation	1	$131
3-d Matrix, Inc.	1	$84
Olympus Corporation Of The Americas	1	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EXALT Model D$41,184
GENERAL - THERAPIES$18,252
FUSION$14,471
SPYGLASS$6,234
GENERAL - BILIARY DEVICES$5,625
EXALT$4,900
EXALT MODEL D CONTROLLER$3,938
EXALT BX 2$3,938
AXIOS$1,625
HABIB ENDOHPB$1,500
GENERAL PAIN MANAGEMENT$598
D.A.S.H.$581
ECHOTIP INSIGHT$225
AUTOTOME$188
Endocuff Vision$149
DISPOSABLE TRIPLE LUMEN SPHINCTEROTOME$149
Single Use Electrosurgical Knife KD-655$149
Single Use Electrosurgical Hemostatic Forceps$149
GENERAL - METAL STENTS - G.I.$145
ACQUIRE$136

How this compares

$154,240 in reported general payments places this provider in the 95th percentile of 323 gastroenterology providers in Indiana.

See all gastroenterology providers in Indiana →

Medicare billing

Part B allowed, 2024

$63,250

Medicare patients

203

Services billed

497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CreonLipase/Protease/Amylase	12	$70,469
Dicyclomine Hcl	19	$544
Omeprazole	23	$424
Pantoprazole Sodium	29	$338
Ciprofloxacin Hcl	14	$42
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	22	$41

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Indianapolis

Douglas RexIndianapolis$557K
Ajay JainIndianapolis$432K
Monika FischerIndianapolis$258K
Naga ChalasaniIndianapolis$255K
Thomas ImperialeIndianapolis$188K
David PoundIndianapolis$137K
Glen LehmanIndianapolis$87K
Samer GawriehIndianapolis$78K
Stuart ShermanIndianapolis$52K
Mohammad Al HaddadIndianapolis$43K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →